Mandy H. Rhenen

One non‐believer: Response to “Obviously Nine Believers: Actionable Germline Genetic Variants for Pre‐emptive Pharmacogenetic Testing”

M. Ingelman-Sundberg, V. Lauschke, H. Guchelaar, 2020, Basic & clinical pharmacology & toxicology.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

Pharmacogenetic Information in Clinical Guidelines: The European Perspective

Hans Mulder, H. Guchelaar, J. Swen, 2018, Clinical pharmacology and therapeutics.